Abstract
Abstract Myasthenia gravis is a heterogeneous disease, and it presents various clinical differences according to the age of onset. Immunological backgrounds that cause these differences are not well understood. Kubota et al. investigated subsets of circulating T and B lymphocytes using various markers. They argued that a reduced percentage of memory B cells seems to be a characteristic of late-onset myasthenia gravis.
| Original language | English |
|---|---|
| Pages (from-to) | 220-221 |
| Number of pages | 2 |
| Journal | Clinical and Experimental Neuroimmunology |
| Volume | 6 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - Jan 1 2015 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Neuroscience (miscellaneous)
- Immunology
- Immunology and Microbiology (miscellaneous)
- Clinical Neurology
Cite this
Implication of circulating memory B cells in late-onset myasthenia gravis. / Murai, Hiroyuki.
In: Clinical and Experimental Neuroimmunology, Vol. 6, No. 3, 01.01.2015, p. 220-221.Research output: Contribution to journal › Short survey
}
TY - JOUR
T1 - Implication of circulating memory B cells in late-onset myasthenia gravis
AU - Murai, Hiroyuki
PY - 2015/1/1
Y1 - 2015/1/1
N2 - Abstract Myasthenia gravis is a heterogeneous disease, and it presents various clinical differences according to the age of onset. Immunological backgrounds that cause these differences are not well understood. Kubota et al. investigated subsets of circulating T and B lymphocytes using various markers. They argued that a reduced percentage of memory B cells seems to be a characteristic of late-onset myasthenia gravis.
AB - Abstract Myasthenia gravis is a heterogeneous disease, and it presents various clinical differences according to the age of onset. Immunological backgrounds that cause these differences are not well understood. Kubota et al. investigated subsets of circulating T and B lymphocytes using various markers. They argued that a reduced percentage of memory B cells seems to be a characteristic of late-onset myasthenia gravis.
UR - http://www.scopus.com/inward/record.url?scp=84938370527&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84938370527&partnerID=8YFLogxK
U2 - 10.1111/cen3.12222
DO - 10.1111/cen3.12222
M3 - Short survey
VL - 6
SP - 220
EP - 221
JO - Clinical and Experimental Neuroimmunology
JF - Clinical and Experimental Neuroimmunology
SN - 1759-1961
IS - 3
ER -